-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVO TO PRESENT NEW LIVER DATA ACROSS WEGOVY 2.4 MG AND INVESTIGATIONAL EFRUXIFERMIN AT LIVER MEETING® (AASLD) 2026

Reuters·10/28/2026 13:06:06